Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Gastroenterology | Pediatrics/Neonatology | Genetic Disease | Neurology

Fabry Disease Clinical Trials

A listing of Fabry Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 Last 

California

Cedars-Sinai Medical Center
Los Angeles California 90048

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Georgia

Department of Human Genetics, Emory University School of Medicine
Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Emory University
Decatur Georgia 30033

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Investigational Site Number 840006
Decatur Georgia 30033

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Illinois

Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Kansas

University of Kansas Medical Center
Kansas City Kansas 66160

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

University of Kansas Medical Center
Kansas City Kansas 66160

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Maryland

Johns Hopkins University School of Medicine
Baltimore Maryland 21205

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Participation in this study is not limited to this facility; facilities not yet active may enroll upon identification of a patient
Cambridge Massachusetts

Patients are needed to participate in a clinical research study evaluating agalsidase beta for the treatment of Fabry Disease

Michigan

Infusion Associates N. E.
Grand Rapids Michigan 49525

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Minnesota

University of Minnesota, Fariview
Minneapolis Minnesota 55455

Patients are needed to participate in a clinical research study of Gabapentin and placebo to evaluate Fabry Disease or Neuropathic Pain

New York

NYU School of Medicine
New York New York 10016

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

North Carolina

Duke University Medical Center
Durham North Carolina 27710

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Ohio

Investigational Site Number 840003
Cincinnati Ohio 45229-3039

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Eye and Ear Institute
Columbus Ohio 43212

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Pennsylvania

Children's Hospital of Pittsburgh of UPMC
Pittsburgh Pennsylvania 15224

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Texas

Baylor Research Institute
Dallas Texas 75204

A Phase 1/2, Open Label, Dose Ranging Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of PRX-102 Administered by Intravenous Infusion Every 2 Weeks for 12 Weeks to Adult Fabry Patients

View More »

Baylor University Medical Center
Dallas Texas 75226

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Research Baylor Institute of Metabolic Disease
Dallas Texas 75226

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Virginia

O & O Alpan
Fairfax Virginia 22030

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

O & O Alpan LLC
Fairfax Virginia 22030

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Investigational Site Number 840002
Fairfax Virginia 22030

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Washington

University of Washington
Seattle Washington 98195-6320

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Wisconsin

Investigational Site Number 840007
Milwaukee Wisconsin 532261

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Argentina

Hospital Universitario Austral
Pilar B1629ODT

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Australia

Women's and Children's Hospital
North Adelaide 5006

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Royal Melbourne Hospital
Parkville Victoria 3050

A clinical research study of migalastat HCl for the treatment of Fabry Disease

Royal Melbourne Hospital
Parkville Victoria 3050

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Royal Melbourne Hospital
Victoria 3050

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Austria

Universitätsklinikum für Neurologie
Graz A-8036

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

Belgium

Investigational Site Number 056001
Liège

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Brazil

Hospital de Clinicas de Porto Alegre
Porto Alegre 90035-001

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Hospital das Clínicas FMUSP - Ribeirão Preto
Ribeirao Preto São Paulo 14048-900

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Canada

Alberta Children's Hospital
Calgary Alberta T3B 6A8
Updated

A Phase 3 clinical study for patients with Fabry Disease

University of Alberta Hospital
Edmonton Alberta T6G 2H7
Updated

A Phase 3 clinical study for patients with Fabry Disease

Izaak Walton Killam (IWK) Health Centre
Halifax Nova Scotia B3K 6R8
Updated

A Phase 3 clinical study for patients with Fabry Disease

Queen Elizabeth II Health Sciences Centre
Halifax Nova Scotia B3H 1V8
Updated

A Phase 3 clinical study for patients with Fabry Disease

Kingston General Hospital
Kingston Ontario K7L 3J6
Updated

A Phase 3 clinical study for patients with Fabry Disease

View More »

London Health Sciences Centre - Victoria Hospital
London Ontario N6C 2V5
Updated

A Phase 3 clinical study for patients with Fabry Disease

Hopital du Sacre-Coeur de Montreal
Montreal Quebec H4J 1C5
Updated

A Phase 3 clinical study for patients with Fabry Disease

Hospital du Sacre-Coeur de Montreal
Montreal Quebec H4J 1C5

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Centre Hospitalier Universitaire de Sherbrooke (CHUS)
Sherbrooke Quebec J1H 5N4
Updated

A Phase 3 clinical study for patients with Fabry Disease

Toronto General Hospital
Toronto Ontario M5G 2C4
Updated

A Phase 3 clinical study for patients with Fabry Disease

The Hospital for Sick Children
Toronto Ontario M5G 1X8
Updated

A Phase 3 clinical study for patients with Fabry Disease

Vancouver General Hospital
Vancouver British Columbia V5Z 1M9
Updated

A Phase 3 clinical study for patients with Fabry Disease

Children's Hospital, Health Sciences Centre Winnipeg
Winnipeg Manitoba R3A 1S1
Updated

A Phase 3 clinical study for patients with Fabry Disease

Croatia

Department of Neurology, University Hospital Sestre Milosrdnice
Zagreb 10000

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

First 1 2 Last